Navigation Links
National Brain Tumor Society Announces the Defeat GBM Research Collaborative’s Project Plans and Investigator Teams
Date:11/19/2013

Newton, MA (PRWEB) November 19, 2013

National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, recently announced further details on its Defeat GBM Research Collaborative, which aims to double the five-year survival rate of patients with glioblastoma multiforme (GBM) – the most common and deadliest form of brain cancer – in just five years. Details include the nature of the four (4) simultaneous and synergistic projects that make up the overall Initiative, as well as the partner institution and/or lead principal investigators responsible for each.

“After we first shared information about the construct of the Defeat GBM Research Collaborative earlier this year, we heard a great amount of enthusiasm from the brain tumor community,” said N. Paul TonThat, CEO, National Brain Tumor Society. “Since then, our staff and advisors have spent a great deal of time planning, discussing, and finalizing the specific research projects, as well as refining the structure to allow each of the individual efforts to feed into the whole. We’re extremely excited to get to work on meeting our goals.”

The timelines, designs, aims, and integration of the projects, as well as how the teams will continuously share and transfer ideas and data as they move along, were solidified during a recent meeting of the world-class brain tumor researchers participating in the Defeat GBM Research Collaborative. The four projects are: target discovery, drug development, predictive biomarkers, and systems biology:

  •     Discovery - Led by Dr. Webster Cavenee & Ludwig Cancer Research
The goal is to identify the right biological target(s) and understand any associated resistance mechanism. Targets identified here will then be triaged into each of the other three (3) projects to help understand how to overcome drug resistance in GBM.
  •     Drug Development - Led by Dr. W.K. Alfred Yung & The University of Texas MD Anderson Cancer Center
The goal is to accelerate drug development by identifying existing molecules/drugs that can be applied specifically to GBM, both on their own and in combination, as well as develop novel drugs (at MD Anderson) specifically for GBM. Simultaneous work in the discovery and biomarker projects will aid the team in matching and creating drugs for different patients and different biological targets.
  •     Predictive Markers (biomarkers) - Led by Dr. Paul Mischel, Dr. Timothy Cloughesy (UCLA) & Ludwig Cancer Research
The goal is to develop predictive marker panels to guide therapy – including combination therapy – for each patient based on the molecular composition of their tumor. These discoveries will then be used to better inform the concurrent drug discovery project stated above, as any markers that are identified as predicating resistance will be screened by the MD Anderson team for drugs, or rational combinations of drug, that can be put together to defeat the particular resistance.
  •     Systems Biology - Led by Dr. Ingo Mellinghoff & Memorial Sloan-Kettering Cancer Center
The goal is to better understand a tumor’s systematic molecular and biological response when attacked with clinical inhibitors of well-characterized GBM mutations (i.e. EGFR and mIDH1). Using systems biology approaches, this project will seek to develop, and then test, rational combinations of inhibitors against these known GBM therapeutic targets. Inhibitors and mutations screened in this project will help supplement observations made in all other projects.

Announced in March of 2013, the Defeat GBM Research Collaborative, a subsidiary of the National Brain Tumor Society, is the Organization’s largest strategic research initiative to-date, and is built around a funding and research model that is designed to rapidly move progress through the drug development pipeline. The Initiative connects leading researchers from top institutions across the country, all of whom previously have a successful track record of collaborating together. A team of Strategic Scientific Advisors will oversee the Initiative and regularly review its progress, and hold the project teams accountable for attaining key milestones and annual goals during the five-year quest.

To learn more, please visit: http://www.DefeatGBM.org

About National Brain Tumor Society
National Brain Tumor Society is the largest nonprofit organization dedicated to the brain tumor community in the United States. We are fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and those who will be diagnosed tomorrow. This means aggressively driving strategic research and advocating for public policies, which meet the critical needs of this community. To learn more, visit http://www.braintumor.org.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11351114.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
2. Annai Systems to Support International Challenge to Improve the Detection of Cancer Mutations
3. International Collaboration Puts the Future of Healthcare IT on Display at the University City Science Center
4. Edison expands international biotechnology presence with launch of full coverage of Athersys
5. Dyadic International Reports Third Quarter 2013 Financial Results
6. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
7. Safety Recommendations Address Blood Clot Prevention for Pregnant Mothers: Physician-Patient Alliance for Health & Safety Presentation at National Perinatal Association Conference
8. PAREXEL International to Present at Jefferies Global Healthcare Conference
9. FAA’s Integration of Civil Unmanned Aircraft Systems in the National Airspace System Roadmap
10. HealthEconomics.Com Distinguished Again as Top Influencer at the International Society for Pharmacoeconomics and Outcomes Research 16th Annual European Congress in Dublin
11. International Survey Finds Self-Administered Treatment on the Rise Among Hereditary Angioedema Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... , ... Global Stem Cells Group has announced an inaugural conference ... Quito, Ecuador, Feb. 24-March 6, 2016. The new facility will provide advanced protocols and ... Stem Cells Group CEO Benito Novas will host the event, which will begin with ...
(Date:2/12/2016)... , Feb. 12, 2016 Biocom, the association representing ... took a group of San Diego ... of its 2016 Precision Medicine Advocacy Fly-In. Biocom Fly-In participants ... and Drug Administration (FDA), the Centers for Medicare and Medicaid ... as San Diego U.S. Representatives Susan Davis and ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Pittcon 2016 Exposition, which ... will include 848 exhibitors (count as of February 9) of which 119 are ... used by the scientific community in industrial, academic, and government labs. The Exposition ...
(Date:2/12/2016)... , Feb. 12, 2016  BD (Becton, Dickinson and ... technology company, today announced the launch of the BD ... and Technology (AGBT) Meeting. --> ... genomic research by providing cost effective NGS library preparation ... a high-throughput, fully integrated, next generation sequencing (NGS) library ...
Breaking Biology Technology:
(Date:2/11/2016)... , Feb. 11, 2016  According to new research ... mainstream. More than 200 fingerprint, iris, and eye-vein ... under 70 brand names. This includes market leaders ... ZTE. Acuity projects that 600 million biometric smartphones ... global installed base. Maxine Most , ...
(Date:2/11/2016)...  Vigilant Solutions announces today that its license plate recognition ... Lee,s Summit Police Department to improve ... of a homicide suspect. Kansas City ... square miles and is home to roughly 100,000 residents. ... mobile license plate reader system and also leverages Vigilant,s network ...
(Date:2/10/2016)... India , February 10, 2016 /PRNewswire/ ... --> According to 2016 iris recognition ... identification iris recognition is more widely accepted ... available with both fingerprint and iris recognition ... the user to avoid purchasing two individual ...
Breaking Biology News(10 mins):